Zobrazeno 1 - 10
of 259
pro vyhledávání: '"Roman Hajek"'
Autor:
Martin Lachnit, Kamila Zondra Revendova, Pavel Hradilek, Radovan Bunganic, Zdenek Koristek, Tomas Jelinek, Monika Skutova, Radim Piza, Ondrej Volny, Roman Hajek, Michal Bar
Publikováno v:
Biomedical Papers, Vol 168, Iss 1, Pp 50-54 (2024)
Introduction. Immunoablative therapy followed by autologous hematopoietic stem cell transplantation (AHSCT) is one of the possible disease-modifying therapies (DMTs) for patients with multiple sclerosis (MS). In this case series, we would like to pre
Externí odkaz:
https://doaj.org/article/173e163f003546e4927c389826380e5a
Thoracoscopic epicardial ablation of atrial fibrillation: Safety, efficacy, single center experience
Publikováno v:
Biomedical Papers, Vol 167, Iss 4, Pp 362-365 (2023)
Aims. Atrial fibrillation (AF) is associated with reduced quality of life and increased risk of ischaemic cerebrovascular events. The left atrial epicardial ablation procedures have evolved towards a successful and safe rhythm control strategy for pa
Externí odkaz:
https://doaj.org/article/e29c4c5d09fc4ea692aa3ecb3044bc90
Autor:
Hana Sahinbegovic, Alexander Vdovin, Renata Snaurova, Michal Durech, Jakub Nezval, Jiri Sobotka, Roman Hajek, Tomas Jelinek, Michal Simicek
Publikováno v:
Current Issues in Molecular Biology, Vol 45, Iss 8, Pp 6717-6727 (2023)
Gene expression is a fundamental process that enables cells to produce specific proteins in a timely and spatially dependent manner. In eukaryotic cells, the complex organization of the cell body requires precise control of protein synthesis and loca
Externí odkaz:
https://doaj.org/article/c556eb38632c44e789243d0b48695f9c
Autor:
Thomas Martin, Meletios-Athanasios Dimopoulos, Joseph Mikhael, Kwee Yong, Marcelo Capra, Thierry Facon, Roman Hajek, Ivan Špička, Ross Baker, Kihyun Kim, Gracia Martinez, Chang-Ki Min, Ludek Pour, Xavier Leleu, Albert Oriol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie-Laure Risse, Philippe Moreau
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Longer-term outcomes with the anti-CD38 antibody isatuximab in combination with carfilzomib-dexamethasone (Isa-Kd) were evaluated in the randomized Phase 3 trial IKEMA (NCT03275285), in a prespecified, follow-up analysis of progression-free
Externí odkaz:
https://doaj.org/article/8e61c702b45741d49f7cd38053f87ec5
Autor:
David Zihala, Tomas Jelinek, Tereza Sevcikova, Anjana Anilkumar Sithara, Veronika Kapustova, Daniel Bilek, Hana Sahinbegovic, Tereza Popkova, Hana Plonkova, Lucie Broskevicova, Ondrej Venglar, Jan Vrana, Vladimir Zidlik, Martin Havel, Zdenek Koristek, Matous Hrdinka, Zuzana Chyra, Michal Simicek, Roman Hajek
Publikováno v:
HemaSphere, Vol 7, p e003730a (2023)
Externí odkaz:
https://doaj.org/article/554b03b769da464b9aa0e4b59f091fed
Autor:
Ivan Spicka, Ido Lapidot, Maximilian Merz, Jakub Radocha, Martin Stork, Tomas Jelínek, Alexandra Jungova, Jiri Minarik, Jan Soukup, Michel Van Speybroeck, Nolen Perualila, Joris Diels, João Duarte Mendes, Kirsten van Nimwegen, Kai Strobel, Sebastien Wischlen, Henrik Sliwka, Blanca Gros Otero, Roman Hajek
Publikováno v:
HemaSphere, Vol 7, p e258126d (2023)
Externí odkaz:
https://doaj.org/article/182f7353616142faae8ea93f217fa58a
Autor:
Alexander Vdovin, Tomas Jelinek, David Zihala, Tereza Sevcikova, Michal Durech, Hana Sahinbegovic, Renata Snaurova, Dhwani Radhakrishnan, Marcello Turi, Zuzana Chyra, Tereza Popkova, Ondrej Venglar, Matous Hrdinka, Roman Hajek, Michal Simicek
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-17 (2022)
Development of proteasome inhibitor resistance is a common problem in patients with multiple myeloma. Here, the authors show that deubiquitinase OTUD1 protects PRDX4 from degradation resulting in increased load of misfolded immunoglobulins sensitizin
Externí odkaz:
https://doaj.org/article/52b4b9da740040788e35b26372435d0d
Autor:
Thomas Martin, Meletios-Athanasios Dimopoulos, Joseph Mikhael, Kwee Yong, Marcelo Capra, Thierry Facon, Roman Hajek, Ivan Špička, Ross Baker, Kihyun Kim, Gracia Martinez, Chang-Ki Min, Ludek Pour, Xavier Leleu, Albert Oriol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie-Laure Risse, Philippe Moreau
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/bbebf16ae9ae4bdab06ac313f9c5c8ac
Autor:
Alyssa Clay-Gilmour, Subhayan Chattopadhyay, Michelle A. T. Hildebrandt, Hauke Thomsen, Niels Weinhold, Pavel Vodicka, Ludmila Vodickova, Per Hoffmann, Markus M. Nöthen, Karl-Heinz Jöckel, Börge Schmidt, Christian Langer, Roman Hajek, Göran Hallmans, Ulrika Pettersson-Kymmer, Claes Ohlsson, Florentin Späth, Richard Houlston, Hartmut Goldschmidt, Elisabet E. Manasanch, Aaron Norman, Shaji Kumar, S. Vincent Rajkumar, Susan Slager, Asta Försti, Celine M. Vachon, Kari Hemminki
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 4, Pp 1-5 (2022)
Externí odkaz:
https://doaj.org/article/63a0fba1d40f4266ac1d3c263ce9d339
Autor:
Pieter Sonneveld, Sonja Zweegman, Michele Cavo, Kazem Nasserinejad, Annemiek Broijl, Rosella Troia, Ludek Pour, Sandra Croockewit, Paolo Corradini, Francesca Patriarca, Kalung Wu, Jolanda Droogendijk, Gerard Bos, Roman Hajek, Maria Teresa Petrucci, Paula Ypma, Nicholas Zojer, Monique C. Minnema, Mario Boccadoro
Publikováno v:
HemaSphere, Vol 6, Iss 10, p e786 (2022)
This phase 2 trial investigated reinduction with carfilzomib, pomalidomide, and dexamethasone (KPd) and continuous pomalidomide/dexamethasone in patients at first progression during lenalidomide maintenance. The second objective was to evaluate high-
Externí odkaz:
https://doaj.org/article/98b6b44e179b444cb4be980901930363